Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder
NCT06376331 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2025-09-05
Summary
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by inattention and hyperactivity-impulsivity. ADHD is often accompanied by oppositional defiant disorder and sleep disturbance, and can increase the risk of other psychiatric disorders, functional impairment in academic and occupational performance. Recently, gut microbiota has been implicated in the ADHD via gut-brain axis. In this study, investigators aimed to evaluate the efficacy of WMT for core ADHD symptoms and its comorbidities using specialized questionnaires for ADHD and investigate the underlying mechanism.
Conditions
- Attention-deficit/Hyperactivity Disorder
Interventions
- DRUG
-
washed microbiota transplantation
The prepared microbiota suspension was infused into the participates' lower gut.
Sponsors & Collaborators
-
Nanjing Medical University
collaborator OTHER -
The Second Hospital of Nanjing Medical University
lead OTHER
Principal Investigators
-
Faming Zhang, PhD · The Second Hospital of Nanjing Medical University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 3 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-28
- Primary Completion
- 2027-06-01
- Completion
- 2027-07-01
Countries
- China
Study Locations
More Related Trials
-
Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials
NCT01063153 ·Status: COMPLETED ·Phase: PHASE4
-
Development of a Multi-faceted Cognitive Training Program for Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01352468 ·Status: COMPLETED ·Phase: NA
-
Evaluation of an Intervention for Improving Community-based Pediatric Attention-Deficit Hyperactivity Disorder (ADHD) Care
NCT01143701 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolic Mechanisms of the Electrophysiological Biomarkers for Response to Methylphenidate Treatment in Children With ADHD
NCT06073470 ·Status: RECRUITING
-
Candidate Gene Screening for Attention Deficit/Hyperactive Disorder (ADHD)
NCT03018574 ·Status: COMPLETED
-
Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD)
NCT01740206 ·Status: COMPLETED ·Phase: NA
-
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
NCT06673368 ·Status: TERMINATED ·Phase: PHASE2
-
Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01238822 ·Status: COMPLETED ·Phase: PHASE4
-
Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)
NCT00000388 ·Status: COMPLETED ·Phase: PHASE4
-
Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)
NCT03709940 ·Status: COMPLETED ·Phase: NA
-
Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD
NCT02430896 ·Status: UNKNOWN
-
Healthy Lifestyle in Adults With Attention Deficit Hyperactivity Disorder
NCT00879320 ·Status: COMPLETED
-
Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)
NCT00862108 ·Status: UNKNOWN ·Phase: PHASE4
-
Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
NCT02247986 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
NCT00050622 ·Status: COMPLETED ·Phase: NA
-
Clinical Efficacy and Long Term Effects of Transcranial Direct Current Stimulation (tDCS) in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
NCT04704687 ·Status: RECRUITING ·Phase: PHASE3
-
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
NCT04421248 ·Status: RECRUITING ·Phase: PHASE4
-
MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response
NCT06906328 ·Status: RECRUITING ·Phase: NA
-
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
NCT00050050 ·Status: COMPLETED ·Phase: PHASE1
-
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
NCT00071656 ·Status: COMPLETED ·Phase: NA
-
Identify Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in ADHD
NCT02074228 ·Status: UNKNOWN ·Phase: PHASE4
-
Preference and Goal Directed Attention Deficit Hyperactivity Disorder Care- Pilot Study
NCT01487967 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Behavioral Treatment Program for Attention Deficit Hyperactivity Disorder, Inattentive Type
NCT00834821 ·Status: COMPLETED ·Phase: NA
-
Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type
NCT00824317 ·Status: COMPLETED ·Phase: NA
-
Mindfulness Training in Adults With ADHD
NCT02463396 ·Status: COMPLETED ·Phase: NA